Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), ...

U.S. IND represents the second regulatory clearance for KLN-1010 and enables the first multi-center clinical trial in the U.S ...

Bringing Decades of Successful Biotech Company Growth, Financing, IPO and M&A ExpertiseNORFOLK, Va.--(BUSINESS WIRE)--ReAlta ...

Vygon, a leading group specialized in the design, manufacturing and marketing of medical devices in neonatology and vascular ...

Sterne, Kessler, Goldstein & Fox proudly announces the election of three new directors effective January 1, 2026. The newly promoted directors are Brian Dudley, Brady Gleason, and Melissa ...

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire ...

Exclusive agreement covers 13 Central and Eastern European marketsCollaboration will help expand access to VANFLYTA for ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

PSI CRO expands its Toronto-area operations with a new office and appoints David Allen as Canada Country Manager to grow ...

New members bring deep experience in pancreatic, colorectal, and anal cancers to guide pelareorep’s development as a platform immunotherapy across GI tumorsCompany continues to strengthen its clinical ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI), certain of the Company’s senior executives and directors, ...